Reinventing clinical trials

Nat Biotechnol. 2012 Jan 9;30(1):41-9. doi: 10.1038/nbt.2083.
No abstract available

MeSH terms

  • Clinical Trials, Phase II as Topic / economics
  • Clinical Trials, Phase II as Topic / standards
  • Clinical Trials, Phase II as Topic / trends*
  • Clinical Trials, Phase III as Topic / economics
  • Clinical Trials, Phase III as Topic / standards
  • Clinical Trials, Phase III as Topic / trends*
  • Drug Approval / statistics & numerical data*
  • Drug Industry
  • Efficiency
  • Electronic Data Processing / methods*
  • Humans
  • National Cancer Institute (U.S.)
  • Safety / standards
  • Technology, Pharmaceutical / economics
  • Technology, Pharmaceutical / trends
  • United States
  • United States Food and Drug Administration